BenzingaBenzinga Japan
BenzingaBenzinga Japan
BenzingaBenzinga Japan
土曜日, 9 26

Healthpeak Properties Inc

DOCNYSE
Trade with Public
Trade with Public
$20.31
0.040.2%
近くで: Sep 25, 5:00 PM EST
$19.90
-0.41-2.02%
時間外: 5:07 PM EST
概要ニュース業績予想目標株価財務センチメント株主構成配当比較オプション株式レポート

Healthpeak Properties Analyst Price Targets

Wall Street analyst price targets and consensus rating for Healthpeak Properties (DOC).

Price Target Range — 12 Quarters

Analyst Consensus — 19 Analysts

7Buy
12Hold
Consensus RatingNeutral# Analysts19Avg. Consensus PT$21Upside to Avg. PT+7.2%

Rating Trend — Last 9 Months

Recent Analyst Actions

すべての評価を見る →
DateFirmAnalystActionRating ChangePrice Target
Sep 21, 2026Evercore ISI GroupJames KammertPT CutIn-Line$23→$22
Sep 15, 2026JefferiesJoe DicksteinAssumesHold$22→$21
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Evercore ISI Group Maintains In-Line on Healthpeak Properties, Lowers Price Target to $22

Evercore ISI Group analyst James Kammert maintains Healthpeak Properties (NYSE:DOC) with a In-Line and lowers the price target from $23 to $22.
Benzinga Newsdesk

PRO
Jefferies Assumes Healthpeak Properties at Hold, Lowers Price Target of $21

Jefferies analyst Joe Dickstein assumes Healthpeak Properties (NYSE:DOC) with a Hold rating and lowers Price Target of $21.
Benzinga Newsdesk

PRO
Barclays Maintains Equal-Weight on Healthpeak Properties, Raises Price Target to $24

Barclays analyst Richard Hightower maintains Healthpeak Properties (NYSE:DOC) with a Equal-Weight and raises the price target from $23 to $24.
Benzinga Newsdesk

Wall Street's Most Accurate Analysts Give Their Take On 3 Real Estate Stocks Delivering High-Dividend Yields

In uncertain markets, investors turn to dividend-yielding stocks. Benzinga provides latest analyst ratings & news for high-yielding stocks.
Avi Kapoor

PRO
Baird Maintains Outperform on Healthpeak Properties, Raises Price Target to $24

Baird analyst Amanda Sweitzer maintains Healthpeak Properties (NYSE:DOC) with a Outperform and raises the price target from $21 to $24.
Benzinga Newsdesk

PRO
Citigroup Maintains Neutral on Healthpeak Properties, Raises Price Target to $22

Citigroup analyst Nick Joseph maintains Healthpeak Properties (NYSE:DOC) with a Neutral and raises the price target from $20 to $22.
Benzinga Newsdesk

データとAPI: Benzinga API · 株式ニュースAPI · アナリスト評価API · 企業ロゴAPI

市場データ提供元 Benzinga API

BenzingaBenzinga Japan

ニュース

パートナーシップ

ベンジンガ・グローバル

© 2026 Benzinga | All Rights Reserved